Allergan has insisted that it’s not afraid of Xiidra, Shire’s brand-new dry eye contender. But it’s adding to its sales force to ensure it has nothing to worry about. The Dublin drugmaker has added 60 ...

Amneal Pharmaceuticals recently received U.S. FDA approvals for its generic versions of RESTASIS® (cyclosporine ophthalmic emulsion 0.05%) and PROAIR® HFA (albuterol sulfate inhalation aerosol 90 mcg) ...

Allergan’s newest DTC campaign for its not-so-new Restasis dry eye medicine focuses on a take-charge woman as the pharma reinvests in TV ads for the 17-year-old brand. The 60-second ad shows a woman ...

Please provide your email address to receive an email when new articles are posted on . Whoa! That sure happened fast. Did you see that coming? The whole dry eye marketplace turned upside down in — ...

Restasis is a brand-name eye drop that’s prescribed for chronic dry eye. The medication is available in single-use and multiuse vials. Restasis is a type of immunosuppressant. Restasis is approved by ...

Please provide your email address to receive an email when new articles are posted on . Have you had anybody who is actually taking a “generic Restasis”? No? Me either. We’ve certainly gotten all ...

Restasis is the second largest Allergan's franchise and it's likely to slow down in 2017 for the competition of Xiidra. The institution of Mylan's IPR litigation by PTAB has increased the chances of ...